China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The firm's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The firm distributes its products within domestic market and to overseas markets.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
8,212
8,212
7,468
8,013
9,150
8,337
Revenue Growth (YoY)
10%
10%
-7%
-12%
10%
20%
Cost of Revenue
2,340
2,340
2,046
1,904
2,114
2,090
Gross Profit
5,871
5,871
5,422
6,109
7,035
6,246
Selling, General & Admin
3,708
3,709
3,441
3,277
3,357
2,981
Research & Development
585
585
329
195
125
114
Operating Expenses
3,990
4,175
3,697
3,393
3,397
3,029
Other Non Operating Income (Expenses)
--
--
0
0
0
-10
Pretax Income
2,103
2,103
2,010
2,873
3,762
3,456
Income Tax Expense
659
659
397
489
486
431
Net Income
1,488
1,488
1,619
2,400
3,258
3,017
Net Income Growth
-8%
-8%
-33%
-26%
8%
19%
Shares Outstanding (Diluted)
2,420.51
2,419.52
2,427.38
2,451.98
2,453.94
2,467.69
Shares Change (YoY)
0%
0%
-1%
0%
-1%
0%
EPS (Diluted)
0.61
0.61
0.66
0.97
1.32
1.22
EPS Growth
-8%
-8%
-32%
-26%
9%
19%
Free Cash Flow
--
--
812
2,184
3,028
2,309
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
71.49%
71.49%
72.6%
76.23%
76.88%
74.91%
Operating Margin
22.9%
20.64%
23.09%
33.88%
39.75%
38.58%
Profit Margin
18.11%
18.11%
21.67%
29.95%
35.6%
36.18%
Free Cash Flow Margin
--
--
10.87%
27.25%
33.09%
27.69%
EBITDA
--
--
1,984
2,944
3,865
3,436
EBITDA Margin
--
--
26.56%
36.74%
42.24%
41.21%
D&A For EBITDA
--
--
259
229
227
219
EBIT
1,881
1,695
1,725
2,715
3,638
3,217
EBIT Margin
22.9%
20.64%
23.09%
33.88%
39.75%
38.58%
Effective Tax Rate
31.33%
31.33%
19.75%
17.02%
12.91%
12.47%
Follow-Up Questions
What are China Medical System Holdings Ltd's key financial statements?
According to the latest financial statement (Form-10K), China Medical System Holdings Ltd has a total asset of $19,198, Net profit of $1,488
What are the key financial ratios for CHSYF?
China Medical System Holdings Ltd's Current ratio is 10.64, has a Net margin is 18.11, sales per share of $3.39.
How is China Medical System Holdings Ltd's revenue broken down by segment or geography?
China Medical System Holdings Ltd largest revenue segment is Pharmaceutical Products, at a revenue of 8,854,663,686 in the most earnings release.For geography, China is the primary market for China Medical System Holdings Ltd, at a revenue of 8,854,663,686.
Is China Medical System Holdings Ltd profitable?
yes, according to the latest financial statements, China Medical System Holdings Ltd has a net profit of $1,488
Does China Medical System Holdings Ltd have any liabilities?
yes, China Medical System Holdings Ltd has liability of 1,803
How many outstanding shares for China Medical System Holdings Ltd?
China Medical System Holdings Ltd has a total outstanding shares of 2,439.52